HEALTH DECISIONS, INC.
Federal contract awards won by HEALTH DECISIONS, INC. (UEI CMKQYLSLNJG1), 2013–2026 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
15
awards
4
expiring in 12 months
1
agency
Category award history
10 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE took Department of Health and Human Services 541715 work from HEALTH DECISIONS, INC. (Oct 21, 2026).
Agencies buying from HEALTH DECISIONS, INC.
What HEALTH DECISIONS, INC. has provided
Awards
NICHD:R&D:CCTN STATISTICAL AND CLINICAL COORDINATING CENTER (SCCC) CORE FUNCTION ACTIVITIES:SEVERABLE
Department of Health and Human Services · $495,123 · Sep 20, 2026
NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE
Department of Health and Human Services · $1,286,724 · Aug 1, 2025
NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE
Department of Health and Human Services · $1,230,826 · May 1, 2025
PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC ANDROGENS AS CONTRACEPTIVE AGENTS
Department of Health and Human Services · $994,099 · Sep 25, 2024
ACQUISITION OF THE NESTORONE ESTRADIOL (NES/E2) VAGINAL RING
Department of Health and Human Services · $1,199,999 · Sep 25, 2024
FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL
Department of Health and Human Services · $2,187,390 · Sep 1, 2023
STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION"
Department of Health and Human Services · $2,330,144 · May 25, 2023
COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
Department of Health and Human Services · $2,968,765 · Jan 1, 2023
TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION
Department of Health and Human Services · $2,493,065 · Sep 24, 2019
TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020.
Department of Health and Human Services · $3,594,685 · Sep 20, 2019
HHSN275201200002I/HHSN27500009 - CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY - HEALTH DECISIONS, INC - CAN 8030701
Department of Health and Human Services · $9,346,474 · Jul 20, 2018
IGF::OT::IGF STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN
Department of Health and Human Services · $3,945,011 · Jul 20, 2017
IGF::OT::IGF COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
Department of Health and Human Services · $9,790,817 · Jul 18, 2017
IGF::OT::IGF CONTRACEPTIVE CLINICAL TRIALS NETWORK TO6 - COORDINATION OF CLINICAL TRIALS OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION -
Department of Health and Human Services · $7,374,299 · Apr 13, 2016
IGF::OT::IGF EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS OF CONTRACEPTIVE EFFICACY AND SAFETY OF MULTIPURPOSE PREVENTION TECHNOLOGIES PRODUCTS
Department of Health and Human Services · $3,170,829 · Sep 24, 2013